chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Imms given 11/30 symptoms began on 12/1. They lasted until approximately 12/2. Patient was noted to be fussy, crying with red face and febrile up to 105.2. Mom reported use of antipyretic meds (ibuprofen and acetaminophen). There was no injection site reaction noted except bruising (no nodules, rash). Patient's mom instructed to bring baby in to ED/UC for evaluation but did not. Symptoms self resolved.
Patient had minor rash after 2 month shots. The rash was worse after her 4 month shots. Dr is blaming pertussis until proven otherwise.
Immediately following pt receiving Pfizer vaccine, she fainted in chair. Symptoms lasted approx 3-4 mins. Medic placed on stretcher and observed for over 30minutes. VS WNLs.  Pt diaphoretic and provided juice, water and peanut butter crackers. Pt's mother reported no PMH.
Nausea, drowsiness, leg pain, red itchy bumps on 10/5/2019 on ankles, legs, abdomen, shoulders
diarrhea; chills; body aches; shortness of breath, when she woke up in the morning; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath, when she woke up in the morning), DIARRHOEA (diarrhea), CHILLS (chills) and MYALGIA (body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced DYSPNOEA (shortness of breath, when she woke up in the morning). On 02-Feb-2021, the patient experienced DIARRHOEA (diarrhea), CHILLS (chills) and MYALGIA (body aches). On 01-Feb-2021, DYSPNOEA (shortness of breath, when she woke up in the morning) outcome was unknown. At the time of the report, DIARRHOEA (diarrhea), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes Tylenol for diarrhea. Concomitant medication for depression and anxiety.
12:00 9AUG pt states lt deltoid started to itch became very red & sore;1PM red, raised hive size of golf ball devel surrounding area from shoulder to below deltoid muscle swollen & hard;pt saw MD 2PM 9AUG;red & inflamed, warm to touch
This spontaneous report was received from a healthcare worker refers to multiple patients of an unknown age and gender. The patients concurrent conditions, pertinent medical history and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored GARDASIL 9 (digital data logger) (lot # L019286, expiration date 14-SEP-2017). The vaccine was exposed to the temperature: 48.9F with the time frame of 1 hour 10 minutes. There was no previous exposure. This is one of the several reports received from the same reporter. Additional information has been requested.
On 4/13/00, the pt received her 2nd dose of Havrix. Four days later, on 4/17/00, the pt experienced abdominal pain, diarrhea and nausea. The most recent information, received on 4/19/00, reports the condition of the pt as ongoing.
Symptoms of rash all over the body. Very itchy! Started with just rash on arm, then went all over the main trunk area. Treatment mainly with prednisone and hydroxyzine. It is much better except for site on ribs (sore). Also using ointments.
Information has been received from a physician for GARDASIL, a Pregnancy Registry product, concerning a 15 year old female with no medical history or allergies who on 18-MAY-2009 was vaccinated intramuscularly with the first and only dose of GARDASIL while pregnant (LMP=end of April 2009, EDD=04-Feb-2010). Concomitant therapy included LUPRON, ROCEPHIN, azithromycin and FLAGYL. No adverse effect reported. Laboratory tests included positive pregnancy test. Medical attention was sought. Follow-up information was received from the physician for GARDASIL, a Pregnancy Registry product, concerning the 15 year old female with post-traumatic stress disorder and conversion disorder. Concomitant therapy included LUPRON, from 18-MAY-2009, 11.25 mg, "93mis" for the menstrual supplement, ROCEPHIN, from 18-MAY-2009, 125 mg, "XT", for "SII tx/presumptive tx", azithromycin, from 18-MAY-2009, 1 gm, "XT", for "SII tx/presumptive tx", and FLAGYL, from 18-MAY-2009, 2 gm, "XT", for the treatment of trichomonas. Estimated conception date is 02-MAY-2009. The patient underwent elective termination on an unknown date within 6 weeks from LMP. Upon internal review, the patient's elective termination was considered to be an other important medical event. Additional information is not available.
Pt rec'd 1st & 2nd dose of vax DEC86 & JAN87 resp; APR87 pt developed generalized osteoarthritis w/pain & swelling in multiple joints; Tx aspirin & Diflunisal; Rec'd 3rd dose JUN87;
Information has been received from a registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 20-FEB-2013, had been administered a dose of GARDASIL (dose, route and lot number not reported) that was exposed to temperature of 11 C. No adverse event was reported. This is one of the reports from the same source. Additional information is not expected.
The day after the first shot, I experienced a severe case of constipation...which I very seldom had over the last 20+ years. I finally had to resort to using a laxative a day later. During this period, due to the constipation I developed a inguinal hernia. The constipation eased slightly until the second shot when it returned in full force. Both times I had severe stomach cramps.
Patient experienced rash on elbow of the same arm of vaccination the day after vaccination & then 2 days after noticed a "pimple"-like bump on her right wrist. The rash went away. The bump is not itchy, blistery or painful. Patient requested for reporting to be completed, but reassured it is not severe.
1445 - administered Hep A vaccine administered Varicella vaccine. 1446 - pt states "I feel like I am going to faint". Pt passes out - shakes hands as passing out. 1447 - called Dr into room. 1449 - pt seen, noted to have seizure activity lasting about 10 seconds and bradycardia to 40.
Chills and low grade fever began at 8:00 pm ~ 12 hours after 2nd dose. Also experienced headache, muscle and joint pain, injection site pain, and nausea. On 4/25 experienced low grade fever in the morning, nausea, headache, tiredness, and feeling unwell throughout the day.
Syncopal Episode-patient eased to floor with no injury DTaP given instead of Tdap
Initial case was received from a consumer on 28 February 2013. An adult female patient (age not reported) received dose one an intradermal injection of FLUZONE intradermal, sanofi pasteur Inc., lot number UT4464AA (site and side not reported) on 25 January 2013. The patient was determined to be 37 weeks gestation at the time of vaccination. The patient's current pregnancy history included kidney stones before the vaccine. She had no treatment for infertility. Date of last menstrual period was reported as 09 May 2012 and estimated date of delivery was reported as 21 February 2013 (did not follow DD/MM/YYYY). On an unspecified date, the patient experienced labor excessive bleeding (reported as current pregnancy history). The patient experienced vaccine insertion site slightly swollen and itchy on unspecified date. Laboratory or diagnostic tests and treatments were not reported. The patient's outcome and pregnancy outcome were not reported. Documents held by sender: None.
Moderna COVID-19  Vaccine  My injection  site started to get red, fevered to the touch, hard and itch and tingle. 7 days after my 1st dose of the vaccine (01/07/2021 . The red site is about the size of a ?playing card.?  I have felt fine other than the place on my arm, NO trouble breathing, no rapid heart rate, no rash.
Symptoms started ~10 minutes after injection.  I began to feel dizzy.  I felt very warm and began to sweat profusely.  My vision got cloudy.  I was given water.  The pharmacist measured my blood pressure, and I believe he said I was 70 over 50.  I began to feel like I was about to pass out, so I laid down and gradually began to improve.  I began to feel very cold instead of very warm.  About thirty minutes later, I felt well enough to leave the pharmacy.  After a couple hours, I began to experience what I think are more typical symptoms - stiffness and pain in the arm which received the shot, and chills.  The next day, I experienced sore wrists, shins, and lower back; fatigue; headache; and hot & cold flashes with uncontrollable shivering or sweating at times.  These symptoms were alleviated about 42 hours after the injection, except for persisting mild pain in the arm had which received the shot.
"On 1/15/21 my right forearm got a bit of a rash that was raised and red. Little island dots up my right arm, itching in my chest. My right knuckles were red, warm, swollen and sore as well as my left but to a lesser extent. Oddly enough I got all my vaccines in my left arm. On 1/15/21 I also noticed my knees were warm and sore but did not look at them. On 1/17/21...{knees and knuckles} Swelling, redness, hot to the touch, a little sore."
Ringing in my ears (tinnitus) has gotten much worse within days of the COVID19 booster shot (3rd shot).
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 15-SEP-2015 the patient was vaccinated with improperly stored ROTATEQ lot # L000434 and expiry date of 10-JUL-2016 orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt started shaking and eyes rolled back momentarily after the Hepatitis A vaccine was given on the right upper arm. Pt received the Menveo vaccine in the left upper arm without problems. Pt assisted to supine position. Vital signs taken and BP 100/80 HR 88, T 98. PT is alert, oriented x 4, cooperative. Pt also complained of mild nausea. After several minutes, pt denies nausea but states "I feel like I'm shaking everywhere. VS at 4 pm BP 124/84, HR 76, SPO2 99. 407 pm, Pt states that the shivering sensation is still present, mild muscle spasms noted on bilateral legs. Product insert for Havrix pulled out and discussed with pt's Mother, discussed that 1-10% of injections will have a CNS adverse reactions including hypertonic episode. VS at 417 pm SPO2 at 99% room air, HR 74, BP 122/86. Pt remains in supine position as of this time. at 425 pm Hypertonic episode persists, pt assisted to sitting position elicited more spasms of the lower extremities. VS at 420 pm BP 120/80 HR 72, SPO2 at room air 99% T 98 F. Pt is alert, oriented x 4, responds appropriately to command. Pt transported to hospital.
8/16/22: Following vaccination with Novavax, patient fainted at clinic and was monitored for 45 minutes (including vital signs ). After going home, patient reports feeling shaky, dizziness, and fatigue.   8/17/22: Patient continued feeling fatigued.   8/18/22: In the morning, patient began having bouts of diarrhea and slight stomach pains, along with continued fatigue. Patient reports that she is trying to stay hydrated and eat, but food "goes right through her." Patient also reports taking pepto but that did not appear to help the diarrhea.
This spontaneous report was received from a female patient of unknown age, reporting on herself. The patient did not have genital warts. The patient's medical history or concurrent conditions were not reported. On an unknown date (reported as from 2000-2004), the patient participated in a Human papillomavirus (HPV) vaccine study and years later she received a letter in which was confirmed that she had received the actual vaccine and not the placebo, therefore, the patient was vaccinated with GARDASIL or GARDASIL 9 for prophylaxis (dosage information, route, lot number and expiration date were not informed). A few years ago, on an unknown date, the patient found out that she had HPV, which obviously surprised her since the test was negative at the end of the study. The patient also reported that she read that the vaccine did not protect against all strains of HPV, but that it did protect against the ones that cause cervical cancer. However, in her early thirties she had two irregular pap smears which showed squamous cells, and she was supposed to get tested every 6 months although she did not have it in a little over a year. The patient also stated that she did not know if this was related to the vaccine or its effectiveness, but she thought she should let someone know in case something was wrong with the vaccine or if it possible to run any tests on her. The outcome of papilloma viral infection and smear cervix abnormal was unknown.
musculoskeletal pain; Chest Pains; Neck Pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest Pains), NECK PAIN (Neck Pain) and MUSCULOSKELETAL PAIN (musculoskeletal pain) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced CHEST PAIN (Chest Pains) and NECK PAIN (Neck Pain). On an unknown date, the patient experienced MUSCULOSKELETAL PAIN (musculoskeletal pain). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Chest Pains) had not resolved, NECK PAIN (Neck Pain) had resolved and MUSCULOSKELETAL PAIN (musculoskeletal pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Aug-2021, Blood pressure measurement: normal (normal) good. On 18-Aug-2021, Lipids normal: normal (normal) good.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  On 13-Aug-2021, the patient started getting neck and chest pains. the patient went to the local ED (emergency department), where they diagnosed with musculoskeletal pain. The patient was advised everything was normal by ED team and was discharged the same day without prolong hospitalization. The patient had also been advised by HCP to take ibuprofen and monitor the symptoms. The patient states that neck pain went away couple of days ago, but chest pain was still ongoing. The patient took blood pressure and cholesterol medications (unspecified).
intussusception 11/18/2009 ED record for 7/30-7/31/2009. DC DX Intussusception Patient with c/o's irritability, vomiting. Xrays + for intussusception which was reduced per air enema. F/up xrays noted resolution. . ICD-9 code 560.0
Patient received Fluzone HD, not Fluzone as his age would have indicated that he receive; patient notified
hives to their arms, face, chest and thighs; itching sensation; flushing sensation; nausea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of URTICARIA (hives to their arms, face, chest and thighs), PRURITUS (itching sensation), FLUSHING (flushing sensation) and NAUSEA (nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced URTICARIA (hives to their arms, face, chest and thighs), PRURITUS (itching sensation), FLUSHING (flushing sensation) and NAUSEA (nausea). At the time of the report, URTICARIA (hives to their arms, face, chest and thighs), PRURITUS (itching sensation), FLUSHING (flushing sensation) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Minor rash on trunk, some spots on upper arms and upper legs; This is a spontaneous report received from a contactable consumer, the patient. A 50-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the left arm on 18Mar2021 at 16:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included sarcoidosis and asthma. The patient had no known allergies to medications, food, or other products. Concomitant medication included leflunomide (MANUFACTURER UNKNOWN), FLOVENT (fluticasone), lactobacillus acidophilus (ACIDOPHILUS), ospemifene (OSPHENA) and MULTIVI (MANUFACTURER UNKNOWN); all for unknown indications from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 07:00, the patient experienced minor rash on trunk, some spots on upper arms and upper legs. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient was treated with over-the-counter BENADRYL for the event. The clinical outcome of the minor rash on trunk, some spots on upper arms and upper legs was recovering.  No follow-up attempts are needed. No further information is expected.
Severely sore left arm; chills, headache; fever; severe  back and knee pain; fatique
Normal flu-like symptoms; Soreness in their arms; Vaccinated 18 hours after puncture of the vial; A spontaneous report was received from a physician concerning a patient who received Moderna COVID-19 vaccine (mRNA-1273) and experienced product storage error, normal flu-like symptoms, and pain in arm.   The patient's medical history was not provided. No relevant concomitant medications were reported.  On 07 Jan 2021, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.   On 07 Jan 2021, the patient was vaccinated with a product that was outside of the 6-hour window from when the vial was punctured. The patient also experienced normal flu-like symptoms and arm soreness.    No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event product storage error was considered recovered/resolved on 07 Jan 2021.  The outcome of the events flu-like symptoms and pain in arm was unknown.  The reporter did not provide an assessment for the events product storage error, flu-like symptoms, and pain in arm..; Reporter's Comments: This case concerns a patient, who experienced non-serious unexpected events of out of specification product use, influenza like illness and pain in extremity. There were no reported AEs associated with this case of out of specification product use. The event of, influenza like illness and pain in extremity occurred on an unspecified date after mRNA-1273 (lot # unknown) administration. The treatment details were not provided. Very limited information regarding this event has been provided at this time.  Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient was given an expired flu vaccine. The flu vaccine that was administered was from the 2020 - 2021 flu season. Patient was informed that she was given an ineffective and expired vaccine and that she will need to be re-vaccinated. Patient did not experience any adverse reactions.
Arm pain at site of injection; Too sore to move normally; This is a spontaneous report from a non-contactable consumer (patient). A 25-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: EN6202), via an unspecified route of administration, administered in the right arm on 26Feb2021 11:00 (at the age of 25-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient did have history of COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Feb2021 14:00, the patient experienced arm pain at site of injection. It was too sore to move normally. Therapeutic measures were not taken as result of the events. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Moderna COVID?19 Vaccine EUA  Nausea, Headache, Fever (102.3 @ 5:00am 3/14) Extreme tiredness
Within an hour of receiving the vaccine I felt a sharp pain shoot down the back of my knee to my heal. I continued to work with the pain.  The next day my knee and calf was sizeably larger.  I went to the urgent care on March 19, 2021.  Then to the Emergency room on March 20, 2021.  They performed an ultrasound of my leg and found a blood clot.  It is in a superficial vein.  Followed up with a vein doctor and will go again in three months for another follow up.
pt recv vax OCT97 & DEC97 pt devel an influenza A infect;dx was made via an unspecified lab test;this is 1 of 3 pt from this site to devel influenza A following receipt of flu vax;
I woke up with pain while putting my shirt on in my arm. It started as a small dot and involved into a soft ball size. In 2 days it went to the size of a quarter and it was raised. I called telehealth and was told to take Benadryl, it went to the size of a softball in like 4-5 days and it stayed like that for a long time and it only contained to my arm because of the Benadryl. It healed after 3 weeks.
Patient has had pain since the vaccine was administered. States it was administered too high. When she lifts her arm behind her back and over shoulder level it causes her joint pain in the shoulder.
6 in L x 4 in W pinkness warmth. No itching no s/sx. No rash.
numbness and pain in arm alway down to fingertips and into chest, hot and red upper arm around and to elbow, fever, nausea, headache, tiredness, could not walk up stiars
Minor but cosistant dry cough, that has persusted for two months and ongoing. Unusually bothersome aches and pains in shoulders neck, other joints My doctor prescribed MethylPREDNISoline 4MG DOSPAK 21S and Abuterol Sulfate inhaler. The steroids help the joint pain right away. The Inhaler didn't do much if anything to help.